Renishaw (OTCMKTS:RNSHF) was upgraded by investment analysts at The Goldman Sachs Group from a “buy” rating to a “conviction-buy” rating in a report released on Thursday, The Fly reports.
Several other equities analysts have also recently issued reports on the stock. Stifel Nicolaus upgraded shares of Renishaw from a “hold” rating to a “buy” rating in a research note on Tuesday, October 26th. Morgan Stanley cut shares of Renishaw from an “equal weight” rating to a “sell” rating and set a $4,399.00 target price for the company. in a research note on Thursday, November 25th. Barclays reiterated a “sell” rating and issued a $4,695.00 target price on shares of Renishaw in a research note on Monday, October 25th. Finally, Zacks Investment Research cut shares of Renishaw from a “buy” rating to a “hold” rating in a research note on Wednesday, December 29th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Renishaw has a consensus rating of “Hold” and a consensus price target of $3,060.67.
RNSHF stock opened at $76.88 on Thursday. The firm’s fifty day simple moving average is $76.65 and its 200-day simple moving average is $73.44. Renishaw has a 12 month low of $63.19 and a 12 month high of $97.00.
Renishaw Plc engages in the design, manufacture, and marketing of metrology and healthcare products. It operates through the Metrology and Healthcare segments. The Metrology segment engages in the fields of industrial automation and motion systems. The Healthcare segment offers engineering solutions for stereotactic neurosurgery, analytical systems that identify and assess biochemical changes associated with disease formation and progression, the supply of specially configured metal additive manufacturing (AM) systems for medical and dental applications, the supply of implants to hospitals and specialist design centres for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture high-quality dental restorations.
Recommended Story: Price Target
Receive News & Ratings for Renishaw Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw and related companies with MarketBeat.com's FREE daily email newsletter.